Compounds > rosiglitazone

Page last updated: 2024-08-25

rosiglitazone and farglitazar

rosiglitazone has been researched along with farglitazar in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (9.09)	18.2507
2000's	7 (63.64)	29.6817
2010's	3 (27.27)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blanchard, SG; Brackeen, MF; Brown, KK; Cobb, JE; Collins, JL; Harrington, WW; Hashim, MA; Henke, BR; Hull-Ryde, EA; Kaldor, I; Kliewer, SA; Lake, DH; Leesnitzer, LM; Lehmann, JM; Lenhard, JM; Miller, JF; Mook, RA; Noble, SA; Oliver, W; Orband-Miller, LA; Parks, DJ; Plunket, KD; Szewczyk, JR; Willson, TM	1
Brown, PJ; Henke, BR; Sternbach, DD; Willson, TM	1
Ayscue, AH; Henke, BR; Lambert, MH; Leesnitzer, LM; Liu, KG; Oliver, WR; Plunket, KD; Sternbach, DD; Willson, TM; Xu, HE	1
Ajamie, RT; Briere, DA; Brozinick, JT; Devanarayan, V; Hawkins, ED; Henry, JR; Li, Y; Misener, EA; Montrose-Rafizadeh, C; Warshawsky, AM; Wilken, B; Yumibe, NP; Zink, RW	1
Chandrasena, G; Chen, S; Cheng, L; Cheng, PT; Devasthale, PV; Doweyko, AM; Farrelly, D; Golla, R; Grover, G; Hariharan, N; Jeon, Y; Ma, Z; Moore, L; Qu, F; Ryono, DE; Seethala, R; Sleph, P; Sun, W; Wang, W; Zhang, H	1
Mochizuki, Y; Nakano, T; Tokiwa, H; Yamada, S; Yamagishi, K; Yamamoto, K	1
Akiyama, TE; Berger, JP; Castriota, G; Chang, CH; Chen, Y; Doebber, TW; Einstein, M; Lau, F; Li, Y; Liu, K; Liu, W; McCann, ME; McKeever, B; McNamara, L; Meinke, PT; Mosley, RT; Wang, C; Wood, HB; Wu, M; Zhou, G	1
Berthelot, P; Beucher-Gaudin, M; Caignard, DH; Dacquet, C; Farce, A; Géant, A; Hennuyer, N; Ktorza, A; Lebegue, N; Leclerc, V; Pirat, C; Staels, B; Zanirato, G	1
Agostini, M; Chatterjee, VK; Garnes, KT; Gurnell, M; Levinson, SH; O'Rahilly, S; Rajanayagam, O; Savage, DB; Schwabe, JW; Smith, AG; Willson, TM; Wood, EM; Xu, HE	1
Chen, J; Chen, Q; Jiang, H; Shen, J; Shen, X; Sun, T	1
Kaya, T; Sheu, SH; Vajda, S; Waxman, DJ	1

Reviews

1 review(s) available for rosiglitazone and farglitazar

Article	Year
The PPARs: from orphan receptors to drug discovery. Journal of medicinal chemistry, 2000, Feb-24, Volume: 43, Issue:4 Topics: Animals; Diabetes Mellitus; Drug Design; Humans; Hyperlipidemias; Hypertension; Inflammation; Ligands; Models, Molecular; Neoplasms; Nuclear Proteins; Obesity; Receptors, Cytoplasmic and Nuclear; Transcription Factors	2000

Other Studies

10 other study(ies) available for rosiglitazone and farglitazar

Article	Year
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents. Journal of medicinal chemistry, 1998, Dec-03, Volume: 41, Issue:25 Topics: Administration, Oral; Aminopyridines; Animals; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; DNA-Binding Proteins; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Ligands; Lipids; Male; Mice; Oxazoles; Propionates; Radioligand Assay; Rats; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; Stereoisomerism; Structure-Activity Relationship; Transcription Factors; Transfection; Tyrosine	1998
Synthesis and biological activity of L-tyrosine-based PPARgamma agonists with reduced molecular weight. Bioorganic & medicinal chemistry letters, 2001, Dec-17, Volume: 11, Issue:24 Topics: Animals; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Male; Molecular Weight; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Tyrosine	2001
Tetrahydroisoquinoline PPARgamma agonists: design of novel, highly selective non-TZD antihyperglycemic agents. Bioorganic & medicinal chemistry letters, 2006, Dec-15, Volume: 16, Issue:24 Topics: Animals; Blood Glucose; Humans; Hypoglycemic Agents; Mice; Models, Molecular; Peroxisome Proliferator-Activated Receptors; PPAR gamma; Rosiglitazone; Tetrahydroisoquinolines; Thiazolidinediones	2006
Discovery of tertiary aminoacids as dual PPARalpha/gamma agonists-I. Bioorganic & medicinal chemistry letters, 2007, Apr-15, Volume: 17, Issue:8 Topics: Amino Acids; Animals; Blood Glucose; Glycine; Hypoglycemic Agents; Hypolipidemic Agents; Mice; Mice, Inbred Strains; PPAR alpha; PPAR gamma; Structure-Activity Relationship	2007
Flexible ligand recognition of peroxisome proliferator-activated receptor-gamma (PPARgamma). Bioorganic & medicinal chemistry letters, 2010, Jun-01, Volume: 20, Issue:11 Topics: Ligands; Models, Molecular; PPAR gamma	2010
Benzimidazolones: a new class of selective peroxisome proliferator-activated receptor γ (PPARγ) modulators. Journal of medicinal chemistry, 2011, Dec-22, Volume: 54, Issue:24 Topics: Animals; Benzimidazoles; Binding Sites; Chlorocebus aethiops; COS Cells; Crystallography, X-Ray; Diabetes Mellitus, Type 2; Dimethadione; Drug Partial Agonism; Gene Expression Profiling; Humans; Hypoglycemic Agents; Male; Mice; Models, Molecular; Mutagenesis; Nuclear Receptor Coactivators; Oxazoles; Pioglitazone; PPAR gamma; Protein Conformation; Rats; Rats, Zucker; Rosiglitazone; Structure-Activity Relationship; Thiazolidinediones; Transcriptional Activation	2011
Anti-diabetic activity of fused PPARγ-SIRT1 ligands with limited body-weight gain by mimicking calorie restriction and decreasing SGK1 expression. European journal of medicinal chemistry, 2017, Sep-08, Volume: 137 Topics: Animals; Body Weight; Caloric Restriction; Cells, Cultured; Chlorocebus aethiops; COS Cells; Dose-Response Relationship, Drug; Gene Expression Profiling; Hypoglycemic Agents; Immediate-Early Proteins; Ligands; Male; Mice; Mice, Obese; Molecular Docking Simulation; Molecular Structure; PPAR gamma; Protein Serine-Threonine Kinases; Sirtuin 1; Structure-Activity Relationship	2017
Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gamma. Endocrinology, 2004, Volume: 145, Issue:4 Topics: Amino Acid Sequence; Cell Line; Gene Expression; Genes, Dominant; Humans; Leucine; Ligands; Methionine; Models, Structural; Molecular Sequence Data; Monocytes; Mutation; Oxazoles; Pioglitazone; Proline; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors; Transfection; Tyrosine; Valine	2004
A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist. Analytical biochemistry, 2004, Dec-15, Volume: 335, Issue:2 Topics: alpha-Galactosidase; Anilides; Cells, Cultured; Chromans; CREB-Binding Protein; Drug Evaluation, Preclinical; Genes, Reporter; Indomethacin; Ligands; Nuclear Proteins; Oxazoles; Pioglitazone; PPAR gamma; Prostaglandin D2; Protein Binding; Rosiglitazone; Thiazolidinediones; Trans-Activators; Troglitazone; Two-Hybrid System Techniques; Tyrosine; Yeasts	2004
Exploring the binding site structure of the PPAR gamma ligand-binding domain by computational solvent mapping. Biochemistry, 2005, Feb-01, Volume: 44, Issue:4 Topics: Alkanesulfonates; Binding Sites; Cinnamates; Computational Biology; Humans; Ligands; Oxazines; Oxazoles; Phenylpropionates; PPAR gamma; Protein Binding; Protein Conformation; Protein Interaction Mapping; Protein Structure, Tertiary; Rosiglitazone; Solvents; Thiazoles; Thiazolidinediones; Thiazolidines; Tyrosine	2005